- For the University
- For external organisations
- Contact us
The UK’s research base is vital to the nation’s success said Rebecca Endean, Director of Strategy at UK Research and Innovation, addressing an audience of 200 at Ideas to Reality 2018, held Wednesday in the Great Hall of King’s College.
“The future economic growth and well being of this country will come from the knowledge base in the country,” Endean said. Her remarks, made less than three weeks after UKRI’s official launch, were warmly received in the hall filled with many of the city’s leading academic entrepreneurs, investors and business partners.
Before her speech, Endean slowly made her way round the Georgian Gothic hall, taking in ten showcased ventures (listed below). She quizzed entrepreneurs about their technologies and asked over and over how government should ideally support research translation. “You are the doers,” she said, “we are just the enablers.”
Apollo Therapeutics—three world-leading universities (Imperial College London, University College London, University of Cambridge) and three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation) together providing translational funding and drug discovery expertise for novel therapeutics, sourced from the best of British academic research, accelerating them towards the clinic
Cambridge GaN Devices—exploiting Gallium Nitride technology for energy-saving, high power electronics applications
Echion Technologies—developing scalable materials innovations for next generation energy storage
Healthera—offering a health management app and cloud software ecosystem to provide a holistic solution to medicine-taking management
Inclusive Design Group—helping designers to understand and consider the diversity of human capabilities
Paragraf—harnessing two-dimensional ‘super-materials’ in real world devices and applications
Polypharmakos—developing novel mechanism of action antimicrobials from natural products
PredictImmune—addressing an unmet need for prognostic tests in immune-mediated diseases
Thermocouple licence—known as the “greatest thermocouple innovation in 50 years”
Waterscope—empowering the planet’s bottom billion to ensure their water is safe with a fast, inexpensive testing method that quantifies waterborne bacteria, on site, within two hours